Urology
Volume 75, Issue 5 , Pages 1138-1143, May 2010

The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis

  • Steven C. Campbell

      Affiliations

    • Edward Hines Jr VA Hospital, Hines, Illinois
    • Corresponding Author InformationReprint requests: Steven C. Campbell, M.D., Ph.D., Section of Urologic Oncology, Glickman Urological and Kidney Institute, 9500 Euclid Ave, Desk A100, Cleveland, OH 44195
    • ,
  • Nirmala Bhoopalam

      Affiliations

    • Edward Hines Jr VA Hospital, Hines, Illinois
    • ,
  • Thomas E. Moritz

      Affiliations

    • Hines VA Cooperative Studies Program Coordinating Center, Hines, Illinois
    • ,
  • Mona Pandya

      Affiliations

    • Edward Hines Jr VA Hospital, Hines, Illinois
    • ,
  • Padmini Iyer

      Affiliations

    • VA Long Beach Health Care System, Long Beach, California
    • ,
  • Peter VanVeldhuizen

      Affiliations

    • Kansas City VA, Kansas City, Missouri
    • ,
  • Nancy K. Ellis

      Affiliations

    • Hines VA Cooperative Studies Program Coordinating Center, Hines, Illinois
    • ,
  • Lizy Thottapurathu

      Affiliations

    • Hines VA Cooperative Studies Program Coordinating Center, Hines, Illinois
    • ,
  • Harinder Garewal

      Affiliations

    • Southern Arizona VA Health Care System, Tucson, Arizona
    • ,
  • Stuart R. Warren

      Affiliations

    • VA Cooperative Studies Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico
    • ,
  • Nicholas Friedman

      Affiliations

    • Edward Hines Jr VA Hospital, Hines, Illinois
    • ,
  • Domenic J. Reda

      Affiliations

    • Hines VA Cooperative Studies Program Coordinating Center, Hines, Illinois

Received 31 August 2009; accepted 21 November 2009. published online 19 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This investigator-initiated study was supported by a grant from Novartis Pharmaceutical Corporation, East Hanover, NJ.

 The protocol design, study conduct, results review, statistical analysis, and protocol monitoring were conducted independently by the Cooperative Studies Coordinating Center, Hines, IL. The study medication was provided by Novartis Pharmaceuticals Corporation and distributed by the Cooperative Studies Clinical Research Pharmacy Coordinating Center, Albuquerque, NM.

 Organizational members of the Zoledronic Acid Trial (The use of zoledronic acid in men on androgen deprivation therapy for prostate cancer with preexisting osteoporosis”) were as follows: Principal investigators (Grant and Protocol development), Steven C. Campbell and Nirmala Bhoopalam; Co-Principal investigator (Grant and Protocol development), H. Garewal; Site Investigators, Steven C. Campbell and N. Bhoopalam (Hines, IL.), P. VanVeldhuizen (Kansas City, MO), P. Iyer (Long Beach, CA), A. Arcenas (Washington, DC), C. Vera (Boston, MA), H Gareval (Tucson, AZ); Cooperative Studies Coordinating Center, Hines, IL (Design, management, monitoring, and analysis of the study), Domenic J. Reda, Thomas E. Moritz, Nancy K. Ellis, Lizy Thottapurathu, Mazen Abdellatif, Jan Motyka; DXA central review, Nicholas Friedman (Hines, IL); Cooperative Studies Clinical Research Pharmacy Coordinating Center (Albuquerque, NM) (distribution of study drug and placebo), Stuart Warren, Jolene Day; Clinical Coordinator, Regina Chorley (Hines, IL.); Site Coordinators, I. Makar (Hines, IL), K. Gomes (Kansas City, MO), C. Kaneshiro (Long Beach, CA); Executive Committee, N. Bhoopalam (Chair), S. Campbell, H. Garewal, N. Friedman, M. Terris, D. J. Reda, S. Warren, T. E. Moritz, R. Chorley, N. K. Ellis, L. Lacerna (Novartis representation); Data Monitoring Board, R. Adler (Chair), M. Gong, G. McCabe, M. Spaulding.

 Participating VA hospitals: Hines VA Medical center, Hines, IL; VA Long Beach Health Care System, Long Beach, CA; Kansas City VA, Kansas City, MO; Southern Arizona VA Health Care System, Tucson, AZ; Washington, DC VA Medical Center, Washington, DC; VA Boston Healthcare System, Jamaica Plain Division, Boston, MA.

PII: S0090-4295(10)00045-2

doi:10.1016/j.urology.2009.11.083

Urology
Volume 75, Issue 5 , Pages 1138-1143, May 2010

Article Tools